Search research articles
Contact Us
Filters
Showing results (161-170 of 845) with videos related to
Page
of 85
Sort By:
Journal of Virology
|
January 1, 1997
Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met)
S M Kang, Z Zhang, C D Morrow
European Journal of Immunology
|
June 1, 1988
The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice
S Izui, M Higaki, D Morrow, et al.
Advances in Experimental Medicine and Biology
|
April 1, 2003
Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid
Erin E Reich, Thomas J Montine, Jason D Morrow
The Journal of Biological Chemistry
|
May 3, 1996
Interaction of ascorbate and alpha-tocopherol in resealed human erythrocyte ghosts. Transmembrane electron transfer and protection from lipid peroxidation
J M May, Z C Qu, J D Morrow
Methods in Enzymology
|
January 1, 1990
Quantification of 9 alpha, 11 beta-prostaglandin F2 by stable isotope dilution mass spectrometric assay
D F Wendelborn, J D Morrow, L J Roberts
Infection and Immunity
|
March 1, 1981
Analysis of human anti-diphtheria antibodies by isoelectric focusing: evidence for restricted clonal heterogeneity of anti-fragment A antibodies
C D Morrow, E M Macy, R H Stevens
Prostaglandins
|
August 1, 1989
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid
J D Morrow, W G Parsons, L J Roberts
Prostaglandins
|
August 1, 1992
The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist
J D Morrow, T A Minton, L J Roberts
Journal of Virology
|
November 1, 1992
In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome
J K Wakefield, S A Jablonski, C D Morrow
Journal of Virology
|
March 1, 1995
Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans
D C Porter, D C Ansardi, C D Morrow
Page
of 85
Search research articles
Search
Showing results (161-170 of 845) with videos related to
Sort By:
Page
of 85
Journal of Virology
|
January 1, 1997
Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met)
S M Kang, Z Zhang, C D Morrow
European Journal of Immunology
|
June 1, 1988
The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice
S Izui, M Higaki, D Morrow, et al.
Advances in Experimental Medicine and Biology
|
April 1, 2003
Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid
Erin E Reich, Thomas J Montine, Jason D Morrow
The Journal of Biological Chemistry
|
May 3, 1996
Interaction of ascorbate and alpha-tocopherol in resealed human erythrocyte ghosts. Transmembrane electron transfer and protection from lipid peroxidation
J M May, Z C Qu, J D Morrow
Methods in Enzymology
|
January 1, 1990
Quantification of 9 alpha, 11 beta-prostaglandin F2 by stable isotope dilution mass spectrometric assay
D F Wendelborn, J D Morrow, L J Roberts
Infection and Immunity
|
March 1, 1981
Analysis of human anti-diphtheria antibodies by isoelectric focusing: evidence for restricted clonal heterogeneity of anti-fragment A antibodies
C D Morrow, E M Macy, R H Stevens
Prostaglandins
|
August 1, 1989
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid
J D Morrow, W G Parsons, L J Roberts
Prostaglandins
|
August 1, 1992
The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist
J D Morrow, T A Minton, L J Roberts
Journal of Virology
|
November 1, 1992
In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome
J K Wakefield, S A Jablonski, C D Morrow
Journal of Virology
|
March 1, 1995
Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans
D C Porter, D C Ansardi, C D Morrow
Page
of 85